First Case of White Dot Syndrome Emerged After COVID-19 Vaccine and Subsequent Infection, Study Shows

First Case of White Dot Syndrome Emerged After COVID-19 Vaccine and Subsequent Infection, Study Shows
A pharmacist prepares a COVID-19 vaccine booster shot in San Rafael, Calif., on Oct. 1, 2021. Justin Sullivan/Getty Images
|Updated:
0:00

Scientists from New Zealand have uncovered the first case of a rare eye disease linked to both the COVID-19 vaccine and the virus itself, a new study published in the Journal of Ophthalmic Inflammation and Infection reveals.

An otherwise healthy 28-year-old patient was diagnosed with multiple evanescent white dot syndrome (MEWDS) after complaining of vision problems just two days after receiving her second dose of the Pfizer-BioNTech vaccine.

Mary Gillis
Mary Gillis
Author
Mary Elizabeth Gillis is a health reporter and cardiopulmonary specialist with over a decade of experience. After graduating with her doctorate in applied physiology, she earned a master of science degree in journalism from Columbia University.
Related Topics